Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fuchs

Showing results (321-330 of 373) with videos related to

Pageof 38
Sort By:
Journal of Hepatology|January 22, 2013
Modulation of the fecal bile acid profile by gut microbiota in cirrhosisGenta Kakiyama, William M Pandak, Patrick M Gillevet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2013
Diagnosis of covert hepatic encephalopathy without specialized testsEiman Nabi, Leroy R Thacker, James B Wade, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 28, 2017
Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosisJasmohan S Bajaj, Andrew Fagan, Masoumeh Sikaroodi, et al.
The American Journal of Gastroenterology|May 11, 2011
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregiversJasmohan S Bajaj, James B Wade, Douglas P Gibson, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
Plos One|April 9, 2013
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 6, 2015
The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging studyVishwadeep Ahluwalia, James B Wade, F Gerard Moeller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2014
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic EncephalopathyJasmohan S Bajaj, Douglas M Heuman, Richard K Sterling, et al.
British Journal of Haematology|November 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
Pageof 38

Showing results (321-330 of 373) with videos related to

Sort By:
Pageof 38
Journal of Hepatology|January 22, 2013
Modulation of the fecal bile acid profile by gut microbiota in cirrhosisGenta Kakiyama, William M Pandak, Patrick M Gillevet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2013
Diagnosis of covert hepatic encephalopathy without specialized testsEiman Nabi, Leroy R Thacker, James B Wade, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 28, 2017
Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosisJasmohan S Bajaj, Andrew Fagan, Masoumeh Sikaroodi, et al.
The American Journal of Gastroenterology|May 11, 2011
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregiversJasmohan S Bajaj, James B Wade, Douglas P Gibson, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
Plos One|April 9, 2013
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 6, 2015
The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging studyVishwadeep Ahluwalia, James B Wade, F Gerard Moeller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2014
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic EncephalopathyJasmohan S Bajaj, Douglas M Heuman, Richard K Sterling, et al.
British Journal of Haematology|November 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
Pageof 38